Article
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
American journal of hematology - 1 Jun 2017
Salem Alireza, Loghavi Sanam, Tang Guilin, Huh Yang O, Jabbour Elias J, Kantarjian Hagop, Wang Wei, Hu Shimin, Luthra Rajyalakshmi, Medeiros L Jeffrey, Khoury Joseph D
Abstract excerpt
Chronic myeloid leukemia (CML) is defined by the presence of t(9;22)(q34;q11.2)/BCR-ABL1. Additional chromosomal abnormalities confer an adverse prognosis and are particularly common in the blast phase of CML (CML-BP). CBFB rearrangement, particularly CBFB-MYH11 fusion resulting from inv(16)(p13.1q22) or t(16;16)(p13.1;q22), is an acute myeloid leukemia (AML)-defining alteration that is associated with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
